Company page

Dyadic International, Inc.

Dyadic International, Inc. (ticker: DYAI) is a public company based in the United States with a market capitalization of approximately $43.4 million. The company focuses on developing and commercializing its proprietary technology for producing biologics and vaccines. Dyadic aims to enhance the efficiency and cost-effectiveness of biopharmaceutical manufacturing processes.